K. Wada

Cerebrospinal fluid lactate and pyruvate concentrations in patients with Parkinson's disease and mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS)

H. Ujike, M. Yamamoto, K. Wada, 1997, Journal of neurology, neurosurgery, and psychiatry.

Expression levels of vascular endothelial growth factor and its receptors in Parkinson's disease

Y. Mizuno, H. Mochizuki, J. Fukae, 2006, Neuroreport.

Neuronal specificity of α-synuclein toxicity and effect of Parkin co-expression in primates

S. Miyachi, M. Takada, N. Ageyama, 2007, Neuroscience.

Cerebrospinal fluid dissemination of anaplastic intraventricular meningioma: report of a case presenting with progressive brainstem dysfunction and multiple cranial nerve palsies

N. Hattori, H. Miwa, A. Kondo, 2016, BMC Neurology.

Posterior reversible encephalopathy syndrome induced after blood transfusion for severe anemia

N. Hattori, H. Miwa, Y. Machida, 2013 .

Effects of UCH‐L1 on α‐synuclein over‐expression mouse model of Parkinson’s disease

N. Hattori, K. Wada, Tomohiro Kabuta, 2009, Journal of neurochemistry.

Correlation between levels of pigment epithelium-derived factor and vascular endothelial growth factor in the striatum of patients with Parkinson's disease

N. Hattori, Y. Mizuno, H. Mochizuki, 2007, Experimental Neurology.

Neuronal specificity of alpha-synuclein toxicity and effect of Parkin co-expression in primates.

S. Miyachi, M. Takada, N. Ageyama, 2007, Neuroscience.